Par Equity portfolio company, Current Health, raises a £31m series B funding round to scale remote patient monitoring

23 April 2021

Par Equity is pleased to continue its support of Current Health, one of the fastest growing tech companies in the UK.

As the first professional investor into Current Health in 2016, it's been an exciting journey so far and Current Health's achievements in the last 12 months alone have been phenomenal. The business has grown rapidly, serving an increasing number of large hospital groups, and now also large pharmaceutical companies, to deliver healthcare at home.

The platform assimilates data from hundreds of remote monitoring devices – including Current Health's own FDA-cleared continuous vital sign monitor – alongside patient-reported symptoms and demographic data to identify and predict the onset and progression of disease.